Ovarian Cancer Trial, Not Yet Recruiting NCT06528236 Sponsor: Zhejiang Provincial People's Hospital Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT06528236
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A gynaecological ultrasound examination found at least one persistent ovarian tumour (a growth on the ovary that did not go away).
  • The person had surgery, and tissue samples from the surgery were examined under a microscope to identify what the growth was.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • The microscopic tissue examination confirmed that the tumour was not located on the ovary.
  • The microscopic tissue examination did not produce a clear or definite result.
  • The ultrasound images have quality problems that make it hard to properly assess the ovarian growth — for example, the mass is too large to fit fully in the image, the images are too blurry (due to the ultrasound equipment, patient movement, focusing issues, or gas in the bowel), the image brightness or contrast settings make the growth hard to evaluate, or image artefacts (distortions) interfere with the assessment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Litao Sun, Professor, Zhejiang Provincial People's Hospital

Phone: 0086 19883106164

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Zhejiang Provincial People's Hospital
Registry
ClinicalTrials.gov
Start date
30 July 2024
Est. completion
30 July 2029

Primary endpoints

Area under the curve

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov